Drug intelligence / Profile preview

lachesis muta

Development stage
Phase 3
Lead developer
Constantine Hering
Administration
Oral, Sublingual
01

Overview

Lachesis is a homeopathic medicinal product derived from the venom of the South American bushmaster snake, *Lachesis muta*. It is a prominent remedy in the homeopathic materia medica, traditionally indicated for conditions characterized by congestion and inflammation, such as menopausal hot flashes, pharyngitis (particularly when symptoms are more severe on the left side), and various circulatory disorders. The manufacturing process follows the standards of the Homeopathic Pharmacopoeia of the United States (HPUS), involving extreme serial dilution and succussion (potentization). While the raw venom contains complex bioactive proteins, including serine proteases and bradykinin-potentiating peptides that affect blood pressure and the coagulation cascade, the finished homeopathic product typically reaches potencies (such as 30C or 200C) where no molecules of the original venom remain. Consequently, it lacks a recognized molecular mechanism of action in conventional pharmacology and is categorized as a homeopathic drug.

Brand names
Boiron Lachesis MutaHyland's LachesisNelson's LachesisDr. Reckeweg LachesisSBL Lachesis
Other names
LachesisBushmaster venomSurucucu venom

Beyond the preview

Go deeper on lachesis muta.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on lachesis muta.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call